US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 0.3651
  • +0.0154+4.40%
Close May 2 16:00 ET
  • 0.3613
  • -0.0038-1.04%
Post 16:41 ET
12.12MMarket Cap-0.14P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.10%83.89M
-28.90%19.08M
1.39%23.01M
-27.69%18.82M
-18.35%22.99M
-35.69%103.7M
-30.68%26.83M
-41.42%22.69M
-42.81%26.03M
-26.49%28.15M
Selling and administrative expenses
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
-General and administrative expense
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
Research and development costs
-15.75%46.18M
-25.43%11M
6.65%11.15M
-21.97%10.72M
-16.11%13.31M
-51.64%54.81M
-45.10%14.75M
-65.76%10.45M
-55.55%13.74M
-36.59%15.86M
Operating profit
19.10%-83.89M
28.90%-19.08M
-1.39%-23.01M
27.69%-18.82M
18.35%-22.99M
35.69%-103.7M
30.68%-26.83M
41.42%-22.69M
42.81%-26.03M
26.49%-28.15M
Net non-operating interest income expense
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
Non-operating interest income
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
Other net income (expense)
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
-115.60%-241.16K
213.60%404.94K
58.20%-630.86K
-112.32%-639.63K
135.11%624.4K
Gain on sale of security
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
94.98%-241.16K
213.60%404.94K
58.20%-630.86K
44.95%-639.63K
135.11%624.4K
Income before tax
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Income tax
Net income
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Net income continuous Operations
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Minority interest income
Net income attributable to the parent company
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Basic earnings per share
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
Diluted earnings per share
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.10%83.89M-28.90%19.08M1.39%23.01M-27.69%18.82M-18.35%22.99M-35.69%103.7M-30.68%26.83M-41.42%22.69M-42.81%26.03M-26.49%28.15M
Selling and administrative expenses -22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M
-General and administrative expense -22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M
Research and development costs -15.75%46.18M-25.43%11M6.65%11.15M-21.97%10.72M-16.11%13.31M-51.64%54.81M-45.10%14.75M-65.76%10.45M-55.55%13.74M-36.59%15.86M
Operating profit 19.10%-83.89M28.90%-19.08M-1.39%-23.01M27.69%-18.82M18.35%-22.99M35.69%-103.7M30.68%-26.83M41.42%-22.69M42.81%-26.03M26.49%-28.15M
Net non-operating interest income expense -31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M
Non-operating interest income -31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M
Other net income (expense) 258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K-115.60%-241.16K213.60%404.94K58.20%-630.86K-112.32%-639.63K135.11%624.4K
Gain on sale of security 258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K94.98%-241.16K213.60%404.94K58.20%-630.86K44.95%-639.63K135.11%624.4K
Income before tax 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Income tax
Net income 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Net income continuous Operations 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Minority interest income
Net income attributable to the parent company 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Basic earnings per share 19.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.87
Diluted earnings per share 19.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Inverse ETF Inverse ETF
No. Symbol Turnover
Sample Name
Sample Code
 3.11B
Sample Name
Sample Code
 1.59B
Sample Name
Sample Code
 553.83M
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
496.91M
5
ProShares UltraPro Short S&P500 ETF
SPXU
397.60M
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 125.760
Sample Name
Sample Code
 597.020
Sample Name
Sample Code
 179.280
4
Oracle
ORCL
150.730
5
ASML Holding
ASML
690.330
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1893
Sample Name
Sample Code
 8.390
Sample Name
Sample Code
 10.970
4
Argo Blockchain
ARBK
0.4265
5
The9 Ltd
NCTY
12.300
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -